Approval was based on results from multiple studies, which demonstrated a slowing of cognitive decline in patients with ...

Campaign encourages the use of low-dose aspirin to help reduce the risk of preeclampsia and the complications that come with ...

A surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.

Application is supported by results from the DEVOTE study, which suggested that two doses of Spinraza (nusinerse) 50 mg taken ...

Under terms of the deal, AbbVie will provide Neomorph with an upfront payment and the potential to earn up to $1.64 billion ...

Paul Howe, chief commercial officer at Protega, discusses efforts to combine high tech solutions with pain-management medications.

Trial findings show long-term recurrence-free survival in patients with low-grade upper tract urothelial cancer treated with ...

As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...

Viralgen and Axovia Therapeutics are partnering to develop and manufacture a gene therapy for the treatment of retinal dystrophy in patients with Bardet-Biedl Syndrome (BBS) caused by biallelic ...